ARTICLE | Clinical News
Intuniv guanfacine extended release: Phase III data
June 1, 2009 7:00 AM UTC
Shire plc (LSE:SHP; NASDAQ:SHPGY), Basingstoke, U.K. Product: Intuniv guanfacine extended release (formerly SPD503, Connexyn) Business: Neurology Molecular target: Adrenoceptor alpha 2a Descriptio...